Consortium of Multiple Sclerosis Centers hosts webcastLIVE TELEPHONE BRIEFING OR LIVE AUDIO WEBCAST TUESDAY, FEBRUARY 28, 11AM –NOON EST
CONSORTIUM OF MULTIPLE SCLEROSIS CENTERS (CMSC) HOSTS MEDIA BRIEFING TO PROVIDE UPDATES ON CURRENT PERSPECTIVES IN MULTIPLE SCLEROSIS CARE
WHAT: A one-hour webcast and teleconference with an interactive Q&A session, hosted by Consortium of Multiple Sclerosis Centers (CMSC) will describe the contemporary vision of multiple sclerosis: the advantages of a comprehensive approach to management; innovative long-term disease management strategies; and an overview of the science of MS and the role of therapy.
WHY: Multiple sclerosis, the most common, non-traumatic, neurological disorder among young adults, is in the public eye now more than ever as new therapies are being investigated and awareness of the disease increases. With two hundred new cases of MS diagnosed each week and an estimated 10,400 new cases per year, it is crucial that people with MS are aware of a new and hopeful vision for this disease. It is equally important that those who treat them are aware of available therapies that can alter the course of the disease combined with symptomatic and rehabilitative therapies that are included in the comprehensive approach of management.
Brian Hutchinson, P.T., President, CMSC and The Heuga Center (moderator)
Randall T. Schapiro, M.D., Founder of the Schapiro Center for MS, University of Minnesota
Bruce Cohen, M.D., Director and Co-Founder of the Northwestern Comprehensive Multiple Sclerosis Program, Professor, Davee Department of Neurology, Feinberg School of Medicine, Northwestern University
Amy Perrin Ross, APRN, MSN, MSCN, CNRN, Neuroscience Program Coordinator, Loyola University Medical Center
WHEN: Tuesday, February 28, 2006
11 AM – noon EST
WHERE: ONLINE at www.mscare.org
OR via toll-free DIAL-IN: (800) 565-5442, Conference confirmation number: 6404585
To register for this event and for additional information, please contact Abby Van Horne AT 212-798-9733 OR [email protected]
Serono, Inc. and Pfizer Inc are pleased to co-sponsor this program with the CMSC.
Published on PsychCentral.com. All rights reserved.